Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients

Completed · Phase 3

Conditions studied: Renal Failure Chronic Requiring Hemodialysis

In brief

The purpose of this study is to confirm the safety and efficacy of Soluble Ferric Pyrophosphate (SFP) dialysate solution in maintaining iron delivery for erythropoiesis in anemic adult patients with chronic kidney disease (CKD) receiving hemodialysis. Efficacy will be measured primarily by the change from baseline in hemoglobin (Hgb).

Key facts

Study ID

NCT01320202

Run by

Rockwell Medical Technologies, Inc.

People needed

305

Starts

2011-03-01

Expected to finish

2013-11-01

Last updated by the study team

2017-04-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Bakersfield, California, United States
• Investigative Site — Chula Vista, California, United States
• Study site — Cudahy, California, United States
• Study site — Downey, California, United States
• Study site — Encino, California, United States
• Study site — Los Angeles, California, United States
• Study site — Los Angeles, California, United States
• Study site — Los Angeles, California, United States
• Study site — Los Angeles, California, United States
• Study site — National City, California, United States
• Study site — Northridge, California, United States
• Study site — Ontario, California, United States
• Study site — Panorama City, California, United States
• Study site — Riverside, California, United States
• Study site — San Dimas, California, United States
• Study site — Simi Valley, California, United States
• Study site — West Covina, California, United States
• Study site — Yuba City, California, United States
• Investigative Site — Waterbury, Connecticut, United States
• Study site — Waterbury, Connecticut, United States
• Study site — Coral Springs, Florida, United States
• Study site — Miami, Florida, United States
• Investigative Site — Augusta, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Michigan City, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.